Total Payments
$497,822
2023 Payments
$39,537
Companies
17
Transactions
234
Payment Breakdown by Category
Consulting$306,455 (61.6%)
Other$97,536 (19.6%)
Travel$88,630 (17.8%)
Food & Beverage$5,137 (1.0%)
Education$64.37 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $306,455 | 78 | 61.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $97,536 | 9 | 19.6% |
| Travel and Lodging | $88,630 | 79 | 17.8% |
| Food and Beverage | $5,137 | 65 | 1.0% |
| Education | $64.37 | 3 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc. | $127,852 | 52 | $0 (2022) |
| Vifor (International) Ltd. | $126,159 | 29 | $0 (2023) |
| SANOFI US SERVICES INC. | $93,127 | 19 | $0 (2019) |
| Relypsa, Inc. | $69,055 | 63 | $0 (2020) |
| Vifor Fresenius Medical Care Renal Pharma Ltd. | $14,387 | 7 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $13,529 | 8 | $0 (2017) |
| Boehringer Ingelheim International GmbH | $10,500 | 3 | $0 (2022) |
| Janssen Research & Development, LLC | $9,842 | 5 | $0 (2017) |
| AstraZeneca AB | $9,740 | 4 | $0 (2019) |
| AstraZeneca UK Limited | $8,703 | 13 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $39,537 | 2 | Vifor (International) Ltd. ($39,000) |
| 2022 | $63,830 | 4 | Vifor (International) Ltd. ($50,000) |
| 2021 | $15,955 | 11 | AstraZeneca UK Limited ($5,750) |
| 2020 | $20,254 | 23 | Bayer HealthCare Pharmaceuticals Inc. ($11,984) |
| 2019 | $144,484 | 76 | SANOFI US SERVICES INC. ($47,729) |
| 2018 | $76,422 | 59 | SANOFI US SERVICES INC. ($34,526) |
| 2017 | $137,340 | 59 | Bayer HealthCare Pharmaceuticals Inc. ($55,455) |
All Payment Transactions
234 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/04/2023 | AstraZeneca UK Limited | — | Consulting Fee | Cash or cash equivalent | $537.00 | General |
| 02/20/2023 | Vifor (International) Ltd. | — | Consulting Fee | Cash or cash equivalent | $39,000.00 | General |
| 06/29/2022 | Boehringer Ingelheim International GmbH | JARDIANCE (Drug) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: DIABETES | ||||||
| 06/29/2022 | Boehringer Ingelheim International GmbH | JARDIANCE (Drug) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: DIABETES | ||||||
| 04/28/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Consulting Fee | Cash or cash equivalent | $7,830.00 | General |
| Category: Cardio-renal | ||||||
| 04/25/2022 | Vifor (International) Ltd. | Veltassa (Drug) | Consulting Fee | Cash or cash equivalent | $50,000.00 | General |
| Category: Potassium Binder | ||||||
| 12/20/2021 | Boehringer Ingelheim International GmbH | JARDIANCE (Drug) | Consulting Fee | Cash or cash equivalent | $4,500.00 | General |
| Category: DIABETES | ||||||
| 11/05/2021 | Vifor Pharma, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,500.00 | General |
| 07/22/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Consulting Fee | Cash or cash equivalent | $435.14 | General |
| Category: Cardio-renal | ||||||
| 03/16/2021 | AstraZeneca UK Limited | — | Consulting Fee | Cash or cash equivalent | $5,000.00 | General |
| 03/16/2021 | AstraZeneca UK Limited | — | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| 01/28/2021 | Bayer HealthCare Pharmaceuticals Inc. | — | Consulting Fee | Cash or cash equivalent | $870.00 | General |
| 01/28/2021 | Bayer HealthCare Pharmaceuticals Inc. | — | Consulting Fee | Cash or cash equivalent | $580.00 | General |
| 01/28/2021 | Bayer HealthCare Pharmaceuticals Inc. | — | Consulting Fee | Cash or cash equivalent | $580.00 | General |
| 01/28/2021 | Bayer HealthCare Pharmaceuticals Inc. | — | Consulting Fee | Cash or cash equivalent | $580.00 | General |
| 01/28/2021 | Bayer HealthCare Pharmaceuticals Inc. | — | Consulting Fee | Cash or cash equivalent | $580.00 | General |
| 01/28/2021 | Bayer HealthCare Pharmaceuticals Inc. | — | Consulting Fee | Cash or cash equivalent | $580.00 | General |
| 12/31/2020 | Relypsa, Inc. | Veltassa (Drug) | Consulting Fee | Cash or cash equivalent | $2,750.00 | General |
| Category: Hyperkalemia | ||||||
| 11/20/2020 | AstraZeneca UK Limited | ONGLYZA (Drug) | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/17/2020 | Eli Lilly and Company | JARDIANCE (Drug) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: Diabetes | ||||||
| 11/13/2020 | Bayer HealthCare Pharmaceuticals Inc. | Non-Covered | Consulting Fee | Cash or cash equivalent | $2,320.00 | General |
| 11/13/2020 | Bayer HealthCare Pharmaceuticals Inc. | Non-Covered | Consulting Fee | Cash or cash equivalent | $580.00 | General |
| 11/13/2020 | Bayer HealthCare Pharmaceuticals Inc. | Non-Covered | Consulting Fee | Cash or cash equivalent | $580.00 | General |
| 11/13/2020 | Bayer HealthCare Pharmaceuticals Inc. | Non-Covered | Consulting Fee | Cash or cash equivalent | $580.00 | General |
| 11/13/2020 | Bayer HealthCare Pharmaceuticals Inc. | Non-Covered | Consulting Fee | Cash or cash equivalent | $580.00 | General |
About Dr. Bertram Pitt, MD
Dr. Bertram Pitt, MD is a Internal Medicine healthcare provider based in Ann Arbor, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1316017742.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bertram Pitt, MD has received a total of $497,822 in payments from pharmaceutical and medical device companies, with $39,537 received in 2023. These payments were reported across 234 transactions from 17 companies. The most common payment nature is "Consulting Fee" ($306,455).
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease
- Location Ann Arbor, MI
- Active Since 11/09/2006
- Last Updated 04/25/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1316017742
Products in Payments
- Veltassa (Drug) $145,336
- SOTAGLIFLOZIN (Drug) $106,539
- Non-Covered $75,269
- Non-Covered (Drug) $40,547
- JARDIANCE (Drug) $13,500
- XARELTO (Drug) $9,842
- Kerendia (Drug) $8,265
- Patiromer (Drug) $7,356
- LOKELMA (Drug) $1,773
- ONGLYZA (Drug) $1,537
- Velphoro (Drug) $163.75
- Livalo (Drug) $145.13
- NO PRODUCT DISCUSSED (Drug) $116.84
- Repatha (Biological) $20.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Ann Arbor
Dr. Marschall Runge, Md, MD
Internal Medicine — Payments: $2.3M
Internal Medicine $2.3M
Terry Smith, M.d, M.D
Internal Medicine — Payments: $2.1M
Internal Medicine $2.1M
Harry Erba, Md, MD
Internal Medicine — Payments: $1.8M
Internal Medicine $1.8M
Dr. Dinesh Khanna, M.d, M.D
Internal Medicine — Payments: $1.2M
Internal Medicine $1.2M
Alexander Yevzlin, Md, MD
Internal Medicine — Payments: $1.2M
Internal Medicine $1.2M
Vallerie Mclaughlin, Md, MD
Internal Medicine — Payments: $1.1M
Internal Medicine $1.1M